2-amino-thiazoline derivatives and their use as inhibitors of inducible nosynthase

Details for Australian Patent Application No. 2002361313 (hide)

International Classifications

Event Publications

10 April 2003 Complete Application Filed

Priority application(s): 60/352,797 30.01.02 US; 01/14510 09.11.01 FR

24 July 2003 Application Open to Public Inspection

Published as AU-B-2002361313

23 August 2007 Application Accepted

Published as AU-B-2002361313

20 December 2007 Standard Patent Sealed

6 March 2008 Corrigenda

Applications Accepted - Name Index Under the name Aventis Pharma S.A., Application No. 2002361313, undr INID (30), correct the priority data to read 2001266124 AU 7 June 2001

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.